Business
Enzolytics, Inc. Announces Appointment of Charles Cotropia as CEO of ENZC and Harry Zhabilov as Its CSO
Enzolytics, Inc. Announces Appointment of Charles Cotropia as CEO of ENZC and Harry Zhabilov as Its CSO.
About this update from Enzolytics Inc.
[{"type":"text","content":"Enzolytics announces the procurement of funding for initial operations of merging entityPLANO, TX / ACCESSWIRE / October 22, 2020 / Enzolytics, Inc. (OTC PINK:ENZC) (or the "Company") announced the appointment, by the Board of Directors of the Company, on October 20 of Charles Cotropia to the position of CEO of Enzolytics. Mr. Cotropia also serves as CEO of ENZC's Merger target BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics"), Harry Zhabilov the former CEO of ENZC has taken the position of CSO. Charles Cotropia was appointed to the ENZC Board of Directors on October 1, 2020. Simultaneously, Harry Zhabilov was appointed to the BCLS board.Charles S. Cotropia is co-founder and CEO of BioClonetics Immunotherapeutics, Inc., a Texas based biotech company with a proprietary methodology for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. Using this methodology, the company has created proprietary cell lines that produce fully human monoclonal antibodies that target and neutralize infectious diseases including HIV, influenza, tetanus and diphtheria.Mr. Cotropia holds a Bachelor of Science degree with honors in Aerospace Engineering from the University of Texas at Austin and a Juris Doctorate Degree from Cornell University. He is a member of the Texas Bar Association and has served as a Member of the Board of Directors of the Dallas Bar Association. He is licensed to practice before the United States Patent and Trademark Office.Prior to his current position at BioClonetics, Mr. Cotropia served as a partner and senior counsel at Sidley Austin LLP in its Dallas office. He has over 45 years of litigation experience having handled cases in the areas of patents, trademarks, trade dress, unfair competition and copyrights. As an intellectual property attorney, he served as lead counsel in patent, trademark, trade dress and copyright disputes litigated in Federal and State Courts and the United States Patent and Trademark Office. In his legal career, Mr. Cotropia represented clients with products and services in many diverse areas, including biotech, aerospace, electronics, the Internet and oil and gas equipment and processes.Harry H. Zhabilov has served as Chairman, President & Chief Science Officer at Immunotech Laborato...